Fluoroquinolone-dependent DNA supercoiling by vaccinia topoisomerase I

Journal of Molecular Biology

Volumn 342, Issue 2, 2004, Pages 479-487

  Kamau, Edwin ^a   Grove, Anne ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

DNA topology; DNA unwinding; enrofloxacin; fluoroquinolone; norfloxacin

Indexed keywords

CIPROFLOXACIN; COUMAMYCIN; DNA; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV; ENROFLOXACIN; LOMEFLOXACIN; MOXIFLOXACIN; NORFLOXACIN; NOVOBIOCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA SUPERCOILING; DRUG EFFECT; ENZYME INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; TRANSCRIPTION INITIATION; VACCINIA; VACCINIA VIRUS;

BACTERIA (MICROORGANISMS);

EID: 4344678806     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2004.06.082     Document Type: Article

References (42)

1. J.C. Wang DNA topoisomerases Annu. Rev. Biochem. 65 1996 635 692
2. J.J. Champoux DNA topoisomerases: structure, function, and mechanism Annu. Rev. Biochem. 70 2001 369 413
3. S. Shuman, and J. Prescott Specific DNA cleavage and binding by vaccinia virus DNA topoisomerase I J. Biol. Chem. 265 1990 17826 17836
4. S. Shuman Site-specific DNA cleavage by vaccinia virus DNA topoisomerase I. Role of nucleotide sequence and DNA secondary structure J. Biol. Chem. 266 1991 1796 1803
5. S. Shuman Site-specific interaction of vaccinia virus topoisomerase I with duplex DNA. Minimal DNA substrate for strand cleavage in vitro J. Biol. Chem. 266 1991 11372 11379
6. S. Shuman, and J. Turner Site-specific interaction of vaccinia virus topoisomerase I with base and sugar moieties in duplex DNA J. Biol. Chem. 268 1993 18943 18950
7. J. Sekiguchi, and S. Shuman Vaccinia topoisomerase binds circumferentially to DNA J. Biol. Chem. 269 1994 31731 31734
8. A. Sharma, R. Hanai, and A. Mondragon Crystal structure of the amino-terminal fragment of vaccinia virus DNA topoisomerase I at 1.6 Å resolution Structure 2 1994 767 777
9. J. Sekiguchi, and S. Shuman Identification of contacts between topoisomerase I and its target DNA by site-specific photocrosslinking EMBO J. 15 1996 3448 3457
10. C. Cheng, P. Kussie, N. Pavletich, and S. Shuman Conservation of structure and mechanism between eukaryotic topoisomerase I and site-specific recombinases Cell 92 1998 841 850
11. C. Cheng, and S. Shuman A catalytic domain of eukaryotic DNA topoisomerase I J. Biol. Chem. 273 1998 11589 11595
12. M.R. Redinbo, L. Stewart, P. Kuhn, J.J. Champoux, and W.G. Hol Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA Science 279 1998 1504 1513
13. F. da Fonseca, and B. Moss Poxvirus DNA topoisomerase knockout mutant exhibits decreased infectivity associated with reduced early transcription Proc. Natl Acad. Sci. USA 100 2003 11291 11296
14. S. Shuman, M. Golder, and B. Moss Characterization of vaccinia virus DNA topoisomerase I expressed in Escherichia coli J. Biol. Chem. 263 1988 16401 16407
15. P.D. Fogelsong, and W.R. Bauer Effects of ATP and inhibitory factors on the activity of vaccinia virus type I topoisomerase J. Virol. 49 1984 1 8
16. R. Shaffer, and P. Traktman Vaccinia virus encapsidates a novel topoisomerase with the properties of a eucaryotic type I enzyme J. Biol. Chem. 262 1987 9309 9315
17. J. Sekiguchi, J.T. Stivers, A.S. Mildvan, and S. Shuman Mechanism of inhibition of vaccinia DNA topoisomerase by novobiocin and coumermycin J. Biol. Chem. 271 1996 2313 2322
18. P.B. Savage Multidrug-resistant bacteria: overcoming antibiotic permeability barriers of gram-negative bacteria Ann. Med. 33 2001 167 171
19. M.S. Sanchez, and J.L. Watts Enhancement of the activity of novobiocin against Escherichia coli by lactoferrin J. Dairy Sci. 82 1999 494 499
20. K. Drlica Mechanism of fluoroquinolone action Curr. Opin. Microbiol. 2 1999 504 508
21. D.C. Hooper Mechanisms of action and resistance of older and newer fluoroquinolones Clin. Infect. Dis. 31 2000 24 28
22. A.B. Khodursky, E.L. Zechiedrich, and N.R. Cozzarelli Topoisomerase IV is a target of quinolones in Escherichia coli Proc. Natl Acad. Sci. USA 92 1995 11801 11805
23. L.L. Shen, and A.G. Pernet Mechanism of inhibition of DNA gyrase by analogues of nalidixic acid: the target of the drugs is DNA Proc. Natl Acad. Sci. USA 82 1985 307 311
24. L.L. Shen, W.E. Kohlbrenner, D. Weigl, and J. Baranowski Mechanism of quinolone inhibition of DNA gyrase. Appearance of unique norfloxacin binding sites in enzyme-DNA complexes J. Biol. Chem. 264 1989 2973 2978
25. G. Palù, S. Valisena, G. Ciarrocchi, B. Gatto, and M. Palumbo Quinolone binding to DNA is mediated by magnesium ions Proc. Natl Acad. Sci. USA 89 1992 9671 9675
26. E.J. Lee, J.-A. Yeo, C.B. Cho, G.J. Lee, S.W. Han, and S.K. Kim Amine group of guanine enhances the binding of norfloxacin antibiotics to DNA Eur. J. Biochem. 267 2000 6018 6024
27. G.S. Son, J.-A. Yeo, M.-S. Kim, S.K. Kim, A. Holmén, B. Åkerman, and B. Nordén Binding mode of norfloxacin to calf thymus DNA J. Am. Chem. Soc. 120 1998 6451 6457
28. M.J. Robinson, B.A. Martin, T.D. Gootz, P.R. McGuirk, M. Moynihan, J.A. Sutcliffe, and N. Osheroff Effects of quinolone derivatives on eukaryotic topoisomerase II. A novel mechanism for enhancement of enzyme-mediated DNA cleavage J. Biol. Chem. 266 1991 14585 14592
29. C.R. Chen, M. Malik, M. Snyder, and K. Drlica DNA gyrase and topoisomerase IV on the bacterial chromosome: quinolone-induced DNA cleavage J. Mol. Biol. 258 1996 627 637
30. K.D. Bromberg, A.B. Burgin, and N. Osheroff Quinolone action against human topoisomerase IIalpha: stimulation of enzyme-mediated double-stranded DNA cleavage Biochemistry 42 2003 3393 3398
31. S. Ikeda, M. Yazawa, and C. Nishimura Antiviral activity and inhibition of topoisomerase by ofloxacin, a new quinolone derivative Antiviral Res. 8 1987 103 113
32. J.T. Stivers, T.K. Harris, and A.S. Mildvan Vaccinia DNA topoisomerase I: evidence supporting a free rotation mechanism for DNA supercoil relaxation Biochemistry 36 1997 5212 5222
33. J.T. Stivers, S. Shuman, and A.S. Mildvan Vaccinia DNA topoisomerase I: single-turnover and steady-state kinetic analysis of the DNA strand cleavage and ligation reactions Biochemistry 33 1994 327 339
34. M.E. Fernandez-Beros, and Y.C. Tse-Dinh Vaccinia virus DNA topoisomerase I preferentially removes positive supercoils from DNA FEBS Letters 384 1996 265 268
35. W. Keller Determination of the number of superhelical turns in simian virus 40 DNA by gel electrophoresis Proc. Natl Acad. Sci. USA 72 1975 4876 4880
36. J. Roca, J.M. Berger, S.C. Harrison, and J.C. Wang DNA transport by a type II topoisomerase: direct evidence for a two-gate mechanism Proc. Natl Acad. Sci. USA 93 1996 4057 4062
37. J.M. Berger, S.J. Gamblin, S.C. Harrison, and J.C. Wang Structure and mechanism of DNA topoisomerase II Nature 379 1996 225 232
38. A. Sugino, and N.R. Cozzarelli The intrinsic ATPase of DNA gyrase J. Biol. Chem. 255 1980 6299 6306
39. S.C. Kampranis, A.D. Bates, and A. Maxwell A model for the mechanism of strand passage by DNA gyrase Proc. Natl Acad. Sci. USA 96 1999 8414 8419
40. B.O. Krogh, and S. Shuman Vaccinia topoisomerase mutants illuminate conformational changes during closure of the protein clamp and assembly of a functional active site J. Biol. Chem. 276 2001 36091 36099
41. S. Shuman DNA strand transfer reactions catalyzed by vaccinia topoisomerase I J. Biol. Chem. 267 1992 8620 8627
42. L. Stewart, M.R. Redinbo, X. Qiu, W.G. Hol, and J.J. Champoux A model for the mechanism of human topoisomerase I Science 279 1998 1534 1541